Neoadjuvant chemotherapy response in breast cancer patients with germline BRCA pathogenic variants

被引：0
|
作者：
Mimata, A. [1 ]
Takahashi, Y. [1 ]
Mamori, T. [1 ]
Nakamoto, S. [1 ]
Tsukioki, T. [1 ]
Iwatani, Y. [1 ]
Tanioka, M. [1 ]
Iwatani, T. [1 ]
Shien, T. [1 ]
机构：
[1] Okayama Univ, Okayama, Japan
来源：
BREAST | 2025年 / 80卷
关键词：
D O I：
10.1016/j.breast.2025.104073
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P232
引用
收藏
页数：2
相关论文
共 50 条
  • [41] EVALUATION OF RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH BREAST CANCER
    Atalay, Can
    Karaman, Niyazi
    Yilmaz, Kerim Bora
    Altinok, Mehmet
    JOURNAL OF BREAST HEALTH, 2007, 3 (01): : 26 - 30
  • [42] In Response to "Pregnancy After Breast Cancer in Patients With Germline BRCA Mutations"
    Narod, Steven A.
    Giannakeas, Vasily
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (36) : 4352 - +
  • [43] A Case of Triple-Negative Breast Cancer with Germline Pathogenic Variants in Both BRCA1 and BRCA2
    Kitahara, Miyuki
    Hozumi, Yasuo
    Machinaga, Mitsuki
    Hayashi, Yuka
    CASE REPORTS IN ONCOLOGY, 2021, 14 (03): : 1645 - 1651
  • [44] Frequency of pathogenic germline mutations beyond Germline BRCA gene mutations among Saudi patients with breast cancer
    Alolayan, Ashwaq
    Sabatin, Fouad
    Algarni, Mohammed
    Mabsout, Nadine
    Zaher, Horya
    Shehata, Hussam
    Alturki, Saeed
    Alshalhoub, Abdulaziz
    Alturki, Fatimah
    Refaea, Sadal
    Abdelhafiz, Nafisah
    Alfayea, Turki
    Alshammari, Kanan
    Albalwi, Mohammed
    CANCER RESEARCH, 2023, 83 (05)
  • [45] A feasibility study of neoadjuvant talazoparib for early-stage breast cancer patients with a germline BRCA pathogenic variant: NCT02282345.
    Litton, Jennifer Keating
    Scoggins, Marion
    Whitman, Gary J.
    Barcenas, Carlos Hernando
    Moulder, Stacy L.
    Murthy, Rashmi Krishna
    Abouharb, Sausan
    Adrada, Beatriz
    Helgason, Thorunn
    Schwartz-Gomez, Jill
    Mittendorf, Elizabeth Ann
    Thompson, Alastair Mark
    Arun, Banu
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [46] Breast cancer outcomes in women with ovarian cancer and a pathogenic germline BRCA mutation
    Ain, Quratul
    O'Connell, Rachel L.
    Swarnkar, Parinita
    Mcveigh, Terri
    George, Angela
    Tasoulis, Marios K.
    Gui, Gerald P. H.
    Wiggins, Jennifer
    Khan, Aadil A.
    Krupa, Katherine D. C.
    Barry, Peter A.
    Banerjee, Susana
    Rusby, Jennifer E.
    EJSO, 2025, 51 (03):
  • [47] CLINICOPATHOLOGICAL CHARACTERISTICS AND BRCA1 /BRCA2 PATHOGENIC VARIANTS OF PATIENTS WITH BREAST CANCER
    Eras, Nazan
    Tuncel, Ferah
    Altintas, Zuhal
    Erden, Sema
    POLISH JOURNAL OF PATHOLOGY, 2024, 75 (01) : 1 - 7
  • [48] Pathogenic germline variants in BRCA and pregnancy rates - data from a German Center of Hereditary Breast and Ovarian Cancer
    Friedrich, Susan
    Speiser, Dorothee
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 192 - 193
  • [49] A significant response to neoadjuvant chemotherapy in BRCA1/2 related breast cancer
    Chapppuis, PO
    Goffin, J
    Wong, N
    Perret, C
    Ghadirian, P
    Tonin, PN
    Foulkes, WD
    JOURNAL OF MEDICAL GENETICS, 2002, 39 (08) : 608 - 610
  • [50] BRCA1 and BRCA2 germline variants in breast cancer patients from the Republic of Macedonia
    Jakimovska, Milena
    Kostovska, Ivana Maleva
    Popovska-Jankovic, Katerina
    Kubelka-Sabit, Katerina
    Karadjozov, Mitko
    Stojanovska, Liljana
    Arsovski, Andreja
    Smichkoska, Snezhana
    Lazarova, Emilija
    Dimitrovska, Maja Jakimovska
    Plaseska-Karanfilska, Dijana
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 168 (03) : 745 - 753
12345